ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email
Roche CEO Thomas Schinecker discusses the company’s third-quarter earnings and recent expansion in China. He outlines some of the recent pharmaceutical developments the business has made, and explains why they have paused investment in Germany.